Antibiotics
-
Rib-X, Sanofi sign research collaboration agreement on antibiotics
Novel technology targets bacterial ribosomes creating an entirely new class of antibiotic therapeutics.
Antibiotics | 11 July 2011
-
Sanofi, Rib-X sign research collaboration agreement on antibiotics
Sanofi announced the signing of an exclusive worldwide research collaboration agreement and option for license with Rib-X Pharmaceuticals Inc for novel classes of antibiotics resulting from Rib-X's RX-04 program for the treatment of resistant Gram-po…
Antibiotics | 01 July 2011
-
Antibiotics that kill hospital and community-acquired infections
Detailed pictures are published showing how an experimental antibiotic can kill bacteria already resistant to existing treatments. The findings could ultimately help scientists to develop new antibiotics to tackle the bacteria responsible for many ho…
Antibiotics | 31 August 2010
-
High-end antibiotics gaining ground in India
The swiftly transforming economic scenario in India has caused a shift in disease patterns and focus from communicable to non-communicable diseases. Despite this, however, infections remain one of the top five causes of mortality. A lack of antib…
Antibiotics | 16 July 2010
-
Most Important Factors Driving Usage of Antibiotics in the ICU
The most important factors that influence antibiotic selection in the intensive care unit (ICU) setting are an agent’s availability in intravenous (IV) formulation, activity against Pseudomonas and extended-spectrum beta lactamase producing pathoge…
Antibiotics | 09 January 2009
-
Report: Antibiotics Market to Recover Reaching $25 Billion by 2010
Report Buyer, the online destination for business intelligence for major industry sectors, has now added a new report on the improving Antibiotics market. “Anti-Infectives, Vol II: Antibacterials,†forecasts a steady recovery and growth to more t…
Antibiotics | 09 May 2007
